Sharper aim: new scan technique may spare healthy kidney tissue during cancer radiation
NCT ID NCT07402109
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to deliver radiation to kidney tumors using advanced imaging to better target the cancer while avoiding healthy tissue. About 40 adults with non-spread kidney cancer will receive this tailored radiotherapy. The goal is to reduce damage to the kidney and preserve its function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiation therapy
- What this could lead to
- If successful, this could lead to a more precise way to treat kidney tumors while preserving kidney function.
- What could go wrong
- This is a small, early-phase study (40 people) focused on imaging technique, not a cure. The added radiation from extra scans is a minor risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA (RCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erasmus MC
RECRUITINGRotterdam, South Holland, 3000CA, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can fasting two days a week slow kidney cancer? a new trial tests the idea
- Cell therapy combo aims to boost kidney cancer treatment
- First-in-Class cancer drug targets Hard-to-Treat tumors
- Immunotherapy after kidney cancer surgery: can a blood test predict who stays Cancer-Free?
- Engineered immune cells take on kidney cancer in first human test
- No clamps, no stitches: new robotic surgery aims to save more kidney function